XLerateHealth selects 7 startups for 2020 accelerator cohort in Louisville

LOUISVILLE, Ky. —  XLerateHealth (XLH), a nationally recognized healthcare accelerator headquartered in Louisville, announced Tuesday the selection of seven startup companies to participate in its 10th cohort. This year’s program will be fully virtual to adapt to COVID-19 precautions. XLH’s portfolio of companies have raised in excess of $93M in institutional and non-dilutive funding.

“We are pleased to support the regional healthcare startup ecosystem in Kentucky and surrounding states,” said Jackie Willmot, CEO and co-founder of XLH. “We have a strong mix of companies participating from the Kentuckiana region as well as national and international entrepreneurs.”

Recently, XLH alumni companies have seen success, including:

  1. Liberate Medical (XLH 2013) received an FDA emergency use authorization for its respiratory muscle stimulator device designed to help wean COVID-19 patients requiring mechanical ventilation off of a ventilator.
  2. Kare Mobile (XLH 2019) CEO Kwane Watson was named president of the American Mobile Dentistry Alliance and the company has secured vendor relationships with industry leaders such as Dental Whale Savings Network, Performance Partners, Bankers Healthcare Group, and more.
  3. Astarte Medical (XLH 2018) signed their first two hospital clients, doubled the size of their team and was featured in Industry Wired as one of the Top 8 U.S. Precision Medicine Companies.
  4. NQ Medical (XLH 2018) has signed contracts with three strategic partners for the development and commercialization of its digital diagnostic technology for detecting Parkinson’s and other central nervous system (CNS) disorders.

The 2020 XLH Louisville startup cohort kicks off its accelerator program on Wednesday, Aug. 5, and will culminate with a virtual Demo Day pitch to investors, healthcare ecosystem partners, and the startup community Oct. 13.

XLerateHealth’s 2020 Louisville Cohort

BooknDoc (New York City, N.Y.) is a SaaS platform that connects doctors with patients that seek medical care in real-time. BooknDoc guarantees priority access for same-day appointments with primary care, specialists and dentists, offering in-practice, telehealth or house-call visits. Doctors optimize their schedule by filling last-minute available slots in real-time. BooknDoc maximizes company benefits packages, reduces operational and total healthcare costs, promotes employee well-being and boosts company performance by reducing employee illness related absenteeism.

Dr. Opinion (San Leandro, Calif.) has developed an AI solution to combat dental insurance fraud, which accounts for over $12.5B in costs to the industry yearly. Supported by pre-trained models and machine learning, the Dr. Opinion platform automatizes claims processing to reduce workload, costs, and human errors in the dental insurance industry. Dr. Opinion is the first AI company with 100% focus on the dental insurance fraud problem.

Glucoconfidence (Louisville, Ky.) is a veteran-owned company that aims to empower people with diabetes to live a life without limits by developing innovative, low-calorie, all-natural liquid glucose supplements for the insulin-taking diabetic community. Available for easy online delivery, these products are developed by people with diabetes, for people with diabetes, and are great tasting, concentrated, and fast-acting, with the optimal osmolality to enhance absorption into the bloodstream.

IBIS Therapeutics (Tampa, Fla.) tackles the problem of therapeutic efficacy using a unique AI engine capable of predicting absorption, distribution, metabolism, excretion and toxicity to identify the best drug candidates from a quarter billion small molecules. IBIS’s first to market product will focus on COVID-19 and inflammation which enables a cost-effective drug discovery process to investigate every protein in the SARS-CoV-2 viral proteome for drug candidates in a few months compared to the time required for traditional compound discovery.

Mediscan (London, England) optimizes hospital processes by leveraging sensor-based AI on a long range, ultrasecure IoT capable network, turning even the oldest hospital infrastructure into a smart facility. With a strategic focus on patient flow, admissions processes, and cyber-physical security, Mediscan has developed an automated operational assistant, “ALICE,” that collects and interprets critical data autonomously so executives can make decisions in real-time. Mediscan simplifies data collection and analysis allowing staff to focus on patient care.

Repaytient (Louisville, Ky.) provides interest and fee-free payment plans to help hospital and clinic patients pay their rising out-of-pocket expenses. They permit these payments to be made over time, which allows patients to receive essential and elective medical care. This ensures patients have the care they need and provides increased cash flow to healthcare facilities and clinics.

RxLightning (New Albany, Ind.) digitizes, automates and streamlines the historically complicated manual enrollment process of starting a patient on specialty medications. Specialty medications are expected to account for 70% of new medication launches through 2023. With RxLightning, healthcare providers can quickly and easily complete the enrollment process for every specialty medication in every therapeutic area, helping reduce paperwork, streamline communication, and accelerate the speed of therapy for patients.